| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 481.40M | 521.10M | 613.90M | 617.00M | 476.20M |
| Gross Profit | 110.10M | 109.70M | 147.00M | 135.50M | 115.60M |
| EBITDA | 49.30M | -5.50M | 31.40M | 20.90M | 41.50M |
| Net Income | -50.60M | -53.40M | -6.80M | -13.20M | 12.80M |
Balance Sheet | |||||
| Total Assets | 394.00M | 512.30M | 655.10M | 707.20M | 671.40M |
| Cash, Cash Equivalents and Short-Term Investments | 38.70M | 69.20M | 74.10M | 65.00M | 68.30M |
| Total Debt | 103.40M | 166.60M | 201.30M | 203.40M | 170.80M |
| Total Liabilities | 246.50M | 317.40M | 384.60M | 410.20M | 341.40M |
| Stockholders Equity | 147.50M | 194.90M | 270.50M | 297.00M | 328.00M |
Cash Flow | |||||
| Free Cash Flow | 34.20M | 33.70M | 38.40M | -1.60M | -2.70M |
| Operating Cash Flow | 42.30M | 40.60M | 62.90M | 12.70M | 14.30M |
| Investing Cash Flow | -8.60M | 3.50M | -27.60M | -22.30M | -8.20M |
| Financing Cash Flow | -62.30M | -62.40M | -19.60M | 400.00K | -8.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £534.43M | 10.73 | 8.34% | 2.09% | 0.49% | 61.73% | |
73 Outperform | £65.18M | 3.57 | 22.93% | ― | 36.61% | ― | |
72 Outperform | £2.62B | 17.58 | 8.06% | 2.12% | 3.15% | -13.57% | |
69 Neutral | £283.07M | 31.22 | 12.26% | 1.89% | 5.46% | -26.44% | |
67 Neutral | £208.56M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £213.67M | -4.02 | -31.21% | ― | -16.33% | -448.12% |